China issued the first medical device price monopoly case ticket. On December 7, the National Development and Reform Commission imposed an administrative penalty on the implementation of the monopoly agreement on the price of medical device products in the field of cardiovascular, reductive therapy and diabetes business by Medtronic (Shanghai) Management Co., Ltd. and its counterparts in the transaction, with a fine of 118.5 million yuan. . The incident brought the medical device market profits to the public again.

How high is the market profit in the medical device industry ? For example, the stent produced by Medtronic, which was investigated this time, has an ex-factory price of only about 1,000 yuan, and the price of the patient's use link has soared to about 30,000 yuan. Such an amazing profit, how many people should envy and hate. Moreover, people stand up and earn money in the right place - after the patients have been slaughtered, they have to be grateful that they have provided imported high-quality stents. If there were news that the pharmaceutical companies were punished, they did not know the 30,000 yuan bracket used, and the value was only 1,000 yuan.

For patients who are already seriously ill, such a huge profit is simply looting. In this regard, some people attribute the reason to a technical monopoly. Who makes the imported brackets of higher quality? The choice of expensive imported stents is voluntary. The internal logic of this analysis is that the quality of the imported stent is more reliable than the domestic stent, so the imported stent forms a technical monopoly on the patient, so the use of this obvious technology monopoly, the use of patients' trust in high-quality stents, the enterprise earns Huge profits. From this point of view, the medical device market profiteering is all the wrong of technology monopoly. To blame, we can only blame foreign companies for being too savvy, and blame domestic companies for not giving force, so patients can only swallow their voices, spend 30 times of money, and install so-called Imported high quality brackets.

Is the reason so simple? First of all, it must be acknowledged that some foreign medical devices are indeed more advanced, and there are technical monopolies in some areas. This is an objective fact that cannot be avoided. However, it must be seen that in addition to the technical monopoly, there is also a sales monopoly formed by the opportunity - the monopoly of the sales level formed by the producers and sellers and the conspiracy of the hospital. This is the realistic foundation for the emergence and realization of profiteering. This kind of sales monopoly is based on the technical monopoly, and at the same time it aggravates the practical impact of the technology monopoly in various ways. To put it bluntly, the interests of all parties regard technological monopoly as a business opportunity for kidnapping patients. What they think is not to actively solve the problem, but to ignite the ignorance, add fuel and vinegar, in the name of technological monopoly, in various ways to continuously increase the degree of monopoly. The opportunity is a piece of your own.

Freeze-Dried RT-PCR Test Reagent Kit Of COVID-19(ORF1ab, N, E)

The Freeze-Dried RT-PCR Test Reagent Kits are for the identification of their described target agent. Use the accompanying assay card for specific information relating to the described target. This instruction booklet describes procedures to perform real-time polymerase chain reaction (PCR) based assays on good quality and advanced pathogen identification device instruments provided by uni-medica. These procedures describe reagent setup and results analysis. For additional information, consult the system manual that accompanied the instrument and the accompanying assay card.

New coronavirus detection reagent,New coronavirus testing reagent,New coronavirus test reagent,Freeze-Dried RT-PCR Test Reagent,freeze-dried PCR reagent

Shenzhen Uni-medica Technology Co.,Ltd , https://www.unimedicadevice.com